Back to trial details

Intake questionnaire

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Applying to Dana-Farber Cancer Institute · Boston, Massachusetts

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Breast Cancer?
3. Are you able to travel to Boston for study visits?